首页> 外文期刊>Turkish Journal of Hematology >Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy
【24h】

Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy

机译:急性髓系白血病患者化疗前后细胞因子表达谱的评估

获取原文
           

摘要

OBJECTIVE: One of the major goals of cancer treatment is the monitoring of chemotherapeutic protocols. Quantitative and comparative cytokine expression profiling could be reliable to be used for biomarkers in deadly and fast-growing cancers such as acute myeloid leukemia (AML). The present study aims to assess and further validate cytokines with probable effects on proliferation and maturation of blood cells in AML. METHODS: Gene expression levels of IL-1β, IL-10, IL-8, TNF-α, and IFN-γ were analyzed before and after chemotherapy and after granulocyte colony-stimulating factor (G-CSF) therapy in 46 AML patients by an in-house quantitative comparative RT-PCR method. RESULTS: Our findings indicated that although the gene expression level of TNF-α was almost constant in all 3 samples, IL-1β, IL-8, and IL-10 expression levels showed a decrease after chemotherapy and an increase after G-CSF therapy. On the other hand, the expression level of IFN-γ had a different pattern with an increase after chemotherapy and a decrease after G-CSF therapy. CONCLUSION: Taken together, the results of this study are in support of the idea that the analyzed cytokines could be useful biomarkers for AML treatment monitoring. However, further molecular epidemiological investigations are suggested to elaborate more cancer monitoring biomarkers.
机译:目的:监测癌症治疗方案的主要目标之一。定量和比较性细胞因子表达谱分析可可靠地用于致命和快速增长的癌症(例如急性髓细胞白血病(AML))中的生物标志物。本研究旨在评估和进一步验证对AML中血细胞增殖和成熟可能具有影响的细胞因子。方法:分析46例AML患者化疗前后,粒细胞集落刺激因子(G-CSF)治疗后IL-1β,IL-10,IL-8,TNF-α和IFN-γ的基因表达水平。内部定量比较RT-PCR方法。结果:我们的研究结果表明,尽管在所有3个样品中TNF-α的基因表达水平几乎恒定,但化疗后IL-1β,IL-8和IL-10的表达水平降低,而G-CSF治疗后的表达水平升高。另一方面,IFN-γ的表达水平具有不同的模式,化疗后增加,而G-CSF治疗后减少。结论:综上所述,本研究的结果支持这样一种观点,即所分析的细胞因子可能是用于AML治疗监测的有用生物标志物。然而,建议进行进一步的分子流行病学研究,以完善更多的癌症监测生物标志物。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号